CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNMD

Price (delayed)

$72.03

Market cap

$2.22B

P/E Ratio

34.3

Dividend/share

$0.8

EPS

$2.1

Enterprise value

$3.17B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
The net income has soared by 180% year-on-year and by 11% since the previous quarter
CNMD's EPS has soared by 178% YoY and by 8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX SYK

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
30.78M
Market cap
$2.22B
Enterprise value
$3.17B
Valuations
Price to earnings (P/E)
34.3
Price to book (P/B)
2.66
Price to sales (P/S)
1.78
EV/EBIT
26.26
EV/EBITDA
23.15
EV/Sales
2.54
Earnings
Revenue
$1.24B
EBIT
$120.6M
EBITDA
$136.8M
Free cash flow
$106.32M
Per share
EPS
$2.1
Free cash flow per share
$3.46
Book value per share
$27.13
Revenue per share
$40.48
TBVPS
$27.44
Balance sheet
Total assets
$2.3B
Total liabilities
$1.47B
Debt
$973.85M
Equity
$834.22M
Working capital
$304.92M
Liquidity
Debt to equity
1.17
Current ratio
1.98
Quick ratio
0.86
Net debt/EBITDA
6.94
Margins
EBITDA margin
11%
Gross margin
54.3%
Net margin
5.2%
Operating margin
9.7%
Efficiency
Return on assets
2.8%
Return on equity
8.2%
Return on invested capital
8.1%
Return on capital employed
6.1%
Return on sales
9.7%
Dividend
Dividend yield
1.11%
DPS
$0.8
Payout ratio
38.1%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
1.34%
1 week
-3.42%
1 month
-5.48%
1 year
-37.15%
YTD
-34.23%
QTD
-10.05%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.24B
Gross profit
$676.25M
Operating income
$120.6M
Net income
$64.46M
Gross margin
54.3%
Net margin
5.2%
The net income has soared by 180% year-on-year and by 11% since the previous quarter
The company's net margin has surged by 168% YoY and by 4% QoQ
The operating income has soared by 74% since the previous quarter
The operating margin has surged by 64% since the previous quarter

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
CNMD P/E details
P/E
34.3
P/B
2.66
P/S
1.78
EV/EBIT
26.26
EV/EBITDA
23.15
EV/Sales
2.54
CNMD's EPS has soared by 178% YoY and by 8% QoQ
The stock's price to book (P/B) is 40% less than its last 4 quarters average of 4.4 and 38% less than its 5-year quarterly average of 4.2
CNMD's equity is up by 12% YoY and by 4.8% from the previous quarter
CNMD's P/S is 43% less than its 5-year quarterly average of 3.1 and 41% less than its last 4 quarters average of 3.0
CNMD's revenue is up by 19% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is CONMED business performance
The ROE has soared by 175% YoY and by 9% from the previous quarter
CNMD's return on assets has surged by 174% year-on-year and by 12% since the previous quarter
CNMD's return on invested capital has surged by 76% since the previous quarter
CNMD's ROS has soared by 64% QoQ

Dividends

What is CNMD's dividend history
Dividend details
DPS
$0.8
Dividend yield
1.11%
Payout ratio
38.1%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 57% greater than its total liabilities
CNMD's quick ratio is up by 25% QoQ and by 16% YoY
The current ratio has grown by 19% from the previous quarter
The company's debt is 17% higher than its equity
The company's debt to equity fell by 17% YoY and by 8% QoQ
CNMD's equity is up by 12% YoY and by 4.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.